Disease Markers

Disease Markers / 2017 / Article

Corrigendum | Open Access

Volume 2017 |Article ID 9617615 | 1 page | https://doi.org/10.1155/2017/9617615

Corrigendum to “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis”

Received12 Jul 2017
Accepted26 Jul 2017
Published20 Aug 2017

In the article titled “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis” [1], the affiliation listed for Dr. O. Stasikowska-Kanicka and Dr. M. Wagrowska-Danilewicz was incorrect. The corrected authors’ list and affiliations are shown above.

References

  1. L. Durko, W. Wlodarski, O. Stasikowska-Kanicka et al., “Expression and clinical significance of cancer stem cell markers CD24, CD44, and CD133 in pancreatic ductal adenocarcinoma and chronic pancreatitis,” Disease Markers, vol. 2017, Article ID 3276806, 7 pages, 2017. View at: Publisher Site | Google Scholar

Copyright © 2017 L. Durko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

450 Views | 186 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.